Pharmaceutical - Women's Health, Anti-Arthritics/Rheumatics

Filter

Popular Filters

EMA pharmacovigilance unit calls for suspension of Protelos/Osseor

EMA pharmacovigilance unit calls for suspension of Protelos/Osseor

10-01-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended…

Anti-Arthritics/RheumaticsEuropeOsseorPharmaceuticalProtelosRegulationServierWomen's Health

New data on Amgen's Prolia and Merck & Co's odanacatib presented at ASBMR meeting

15-10-2012

Amgen (Nasdaq: AMGN), the world's largest biotech firm, has presented data from several Prolia (denosumab)…

AmgenAnti-Arthritics/RheumaticsBiotechnologyMerck & CoodanacatibPharmaceuticalProliaResearchWomen's Health

EMA accepts Pfizer's bazedoxifene/CE marketing application

20-07-2012

The European Medicines Agency has accepted for review drug behemoth Pfizer's (NYSE: PFE) Marketing Authorization…

Anti-Arthritics/RheumaticsbazedoxifeneEuropePfizerPharmaceuticalRegulationWomen's Health

FDA approves Bayer HMB drug Natazia and EffRx osteo drug Binosto

15-03-2012

German drug major Bayer (BAY: DE) says its US subsidiary has received approval from the Food and Drug…

Anti-Arthritics/RheumaticsBayerBinostoEffRx PharmaceuticalsNataziaNorth AmericaPharmaceuticalRegulationWomen's Health

Takeda’s Steovess accepted for national approvals in EU

23-12-2011

Japan’s largest drugmaker Takeda Pharmaceuticals (TYO: 4502) says that the European decentralized…

Anti-Arthritics/RheumaticsEffRx PharmaceuticalsEuropePharmaceuticalRegulationSteovessTakeda PharmaceuticalsWomen's Health

Parexel

Parexel

Back to top